Back
Evaxion Biotech AS Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Sell
6
EVAX
Evaxion Biotech AS
Last Price:
2.57
Seasonality Move:
-49.13%
Sell
29
ADAP
Adaptimmune Therapeutics PLC
Last Price:
0.80
Seasonality Move:
35.83%
Sell
6
Evaxion Biotech AS (EVAX)
is a Sell
Is Evaxion Biotech AS a Buy, Sell or Hold?
- The current Evaxion Biotech AS [EVAX] share price is $2.50. The Score for EVAX is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
- EVAX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
29
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.80. The Score for ADAP is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EVAX Stock Price Chart
What is Evaxion Biotech AS's stock price today?
-
The Evaxion Biotech AS share price today is $2.50
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EVAX is experiencing slight selling pressure.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $0.80
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing buying pressure, which is a positive indicator for future bullish movement.
EVAX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.08 | Sell |
Relative Strength Index (14 RSI): | 39.56 | Sell |
Chaikin Money Flow: | -9582 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.58 - 2.8) | Sell |
Bollinger Bands (100): | (2.66 - 3.16) | Sell |
ADAP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 44.32 | Sell |
Chaikin Money Flow: | 606950 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.75 - 0.89) | Sell |
Bollinger Bands (100): | (0.86 - 1.2) | Sell |
EVAX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.62 | Sell |
20-day SMA: | 2.66 | Sell |
50-day SMA: | 2.9 | Sell |
200-day SMA: | 3.37 | Sell |
8-day EMA: | 2.61 | Sell |
20-day EMA: | 2.69 | Sell |
50-day EMA: | 2.82 | Sell |
200-day EMA: | 4.13 | Sell |
ADAP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.78 | Buy |
20-day SMA: | 0.8 | Sell |
50-day SMA: | 0.93 | Sell |
200-day SMA: | 1.13 | Sell |
8-day EMA: | 0.79 | Buy |
20-day EMA: | 0.81 | Sell |
50-day EMA: | 0.9 | Sell |
200-day EMA: | 1.03 | Sell |
Evaxion Biotech AS Earnings Growth & EVAX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.58 per share, and an increase next year of $0.04 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.34 per share.
Evaxion Biotech AS Technical Analysis
Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Adaptimmune Therapeutics PLC Technical Analysis
Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |